Approval of mifepristone (RU 486) in Europe;Zulassung von mifepristone (RU 486) in Europa

Zentralblatt fur Gynakologie

Volumn 122, Issue 5, 2000, Pages 241-247

  Sitruk Ware, Régine ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antiglucocorticoid; Antiprogestins; Breast cancer; Cervical ripening; Contraception; Endometriosis; Gemeprost; Labor induction; Leiomyomas; Meningiomas; Mifepristone; Misoprostol; Terminat ion of pregnancy

Indexed keywords

ANTIGESTAGEN; GEMEPROST; GLUCOCORTICOID ANTAGONIST; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2 DERIVATIVE; SULPROSTONE;

BREAST CANCER; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; ENDOMETRIOSIS; EUROPE; FEMALE; HUMAN; LABOR INDUCTION; LEIOMYOMA; MENINGIOMA; NONHUMAN; PREGNANCY TERMINATION; REVIEW; UTERINE CERVIX DILATATION;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ANIMALS; DRUG APPROVAL; EUROPE; FEMALE; HUMANS; MIFEPRISTONE; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0034083576     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Ashok PW, Penney GC, Flett GMM et al. An effective regimen for early medical abortion: a report of 2 000 consecutive cases. Hum Reprod 1988; 10, (Suppl. 10): 2962-2965
2. Aubeny E, Peyron R, Turpin CC et al. Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol. Int J Fertil 1995; 40: 85-91
3. Baird DT, Sukcharoen N, Thong KJ. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 1995; 10: 1521-1527
4. Baulieu EE. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 1989; 245: 1351-1357
5. Bygdeman M, Swahn ML. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 1985; 32: 45-51
6. Cabrol D, Dubois C, Cronje H et al. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol 1990; 163: 540-542
7. Cheng L, Kelly RW, Thong KJ et al. The effect of mifepristone (RU 486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy. J Clin Endocrinol Metab 1993; 77: 873-877
8. Chwalisz K, Stockemann K, Fuhrmann U et al. Mechanism of action of antiprogestins in the pregnant uterus. Ann NY Acad Sci 1995; 761: 202-223
9. Cohn M, Stewart P. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study. Br J Obstet Gynaecol 1991; 98: 778-782
10. Croxatto HB, Salvatierra AM, Croxatto HD et al. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod 1993; 8: 201-207
11. El-Refaey H, Rajasekar D, Abdalla M et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-987
12. Frydman R, Lelaidier C, Baton-Saint-Mleux C et al. Labor induction in women at term with mifepristone (RU486): A double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992; 80: 972-975
13. Grunberg SM, Weiss MH, Spitz IM et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 1991; 74: 861-866
14. Gupta JK, Johnson N. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion. Contraception 1992; 46: 489-497
15. Henshaw RC, Naji SA, Russell IT et al. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993; 307: 714-717
16. Henshaw RC, Templeton AA. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486). Br J Obstet Gynaecol 1991; 98: 1025-1030
17. Ho PC, Tsang SSK, Ma HK. Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent. Br J Obstet Gynaecol 1995; 102: 648-651
18. Howie FL, Henshaw RC, Naji SA et al. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104: 829-833
19. Kettel LM, Murphy AA, Morales AJ et al. Preliminary report on the treatment of endometriosis with low dose mifepristone (RU 486). Am J Obstet Gynecol 1998; 178: 1151-1156
20. Lefebvre Y, Proulx L, Elie R et al. The effects of RU-38486 on cervical ripening. Am J Obstet Gynecol 1990; 162: 61-65
21. Marions L, Gemzell-Danielsson K, Swahn ML et al. Contraceptive efficacy of low doses of mifepristone. Fertil Steril 1998; 70: 813-816
22. Murphy AA, Morales AJ, Kettel LM et al. Regression of uterine leiomyomata to the antiprogesterone RU 486: dose-response effect. Fertil Steril 1995; 64: 187-190
23. Nieman LK, Chrousos GP, Kellner C et al. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985; 61: 536-540
24. Padayachi T, Moodley J, Norman RJ et al. Termination of pregnancy with mifepristone after intra-uterine death. Clinical and hormonal effects. S Afr Med J 1989; 75: 540-542
25. Perrault D, Eisenhauer EA, Pritchard KI et al. Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol 1996; 14: 2709-2712
26. Peyron R, Aubeny E, Targosz V et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. New Engl J Med 1993; 328: 1509-1513
27. Pons J-C, Imbert M-C, Elefant E et al. Development after exposure to mifepristone in early pregnancy. Lancet 1991; 338: 763
28. Radestad A, Bygdeman M. Are prostaglandins mediators of Mifepristone (RU 486)-induced cervical softening in early pregnancy. J Lipid Mediators 1993; 6: 503-507
29. Rodger MW, Baird DT. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990; 97: 41-45
30. Schaff EA, Stadalius LS, Eisinger SH et al. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract 1997; 44: 353-360
31. Sitruk-Ware R, Davey A, Sakiz E. Fetal malformation and failed medical termination of pregnancy. Lancet 1998; 352: 323
32. Spitz IM, Bardin CW. Clinical pharmacology of RU 486 - An antiprogestin and antiglucocorticoid. Contraception 1993; 48: 403-444
33. Spitz IM, Benton L, Bardin CW et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241-1247
34. Taskforce on post-ovulatory methods of fertility regulation. Comparison of three doses of mifepristone as emergency contraception. Lancet 1999; 353: 697-702
35. UK Multicenter Study Group. (McKenzie I et al.) Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. Contraception 1997; 56: 361-366
36. Ulmann A, Barnard J. Termination of pregnancy with mifepristone. BMJ 1993; 307: 684
37. Urquhart DR, Templeton AA, Shimewi F et al. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation - U. K. multicenter study final results. Contraception 1997; 55: 1-5
38. Van Look PFA and the WHO: Taskforce on post-ovulatory methods of fertility regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532-537
39. World Health Organisation. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. Br J Obstet Gynecol 1990; 97: 260-266